Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127539561 | 12753956 | 1 | I | 20160908 | 20160916 | 20160916 | EXP | IT-JNJFOC-20160908426 | JANSSEN | AVOLA N, GUZZARDI S, SPADARO D, MARLETTA E, VALERIO A, REGOLO S, ET AL. THE IMPORTANCE OF REPORTING LACK OF THERAPEUTIC RESPONSE: THE OLANZAPINE CASE IN THE SYRACUSE PROVINCIAL HEALTH AUTHORITY. EUROPEAN JOURNAL OF HOSPITAL PHARMACY 2014;21:A73-A74. | 37.00 | YR | A | Y | 0.00000 | 20160916 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127539561 | 12753956 | 1 | PS | INVEGA | PALIPERIDONE | 1 | Oral | U | U | 21999 | 9 | MG | OROS (ORAL OSMOTIC) THERAPEUTIC SYSTEM TABLET | ||||||
| 127539561 | 12753956 | 2 | SS | ZYPREXA | OLANZAPINE | 1 | Unknown | U | 0 | 10 | MG | UNSPECIFIED | |||||||
| 127539561 | 12753956 | 3 | SS | ZYPREXA | OLANZAPINE | 1 | Unknown | U | 0 | 10 | MG | UNSPECIFIED | |||||||
| 127539561 | 12753956 | 4 | SS | ZYPREXA | OLANZAPINE | 1 | Unknown | U | 0 | 10 | MG | UNSPECIFIED | |||||||
| 127539561 | 12753956 | 5 | SS | ZYPREXA | OLANZAPINE | 1 | Unknown | U | 0 | 10 | MG | UNSPECIFIED | |||||||
| 127539561 | 12753956 | 6 | SS | FELISON | FLURAZEPAM MONOHYDROCHLORIDE | 1 | Unknown | U | 0 | 30 | MG | UNSPECIFIED | |||||||
| 127539561 | 12753956 | 7 | SS | NOZINAN | LEVOMEPROMAZINE | 1 | Unknown | U | 0 | 25 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127539561 | 12753956 | 1 | Product used for unknown indication |
| 127539561 | 12753956 | 2 | Psychotic disorder |
| 127539561 | 12753956 | 3 | Schizophrenia |
| 127539561 | 12753956 | 4 | Schizophrenia |
| 127539561 | 12753956 | 5 | Bipolar disorder |
| 127539561 | 12753956 | 6 | Product used for unknown indication |
| 127539561 | 12753956 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127539561 | 12753956 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127539561 | 12753956 | Intentional overdose | |
| 127539561 | 12753956 | Suicide attempt |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |